Specialty Drugs
Meeting Patients Where They Are Helps Keep SP Medications on Track
Addressing access, affordability and other social determinants of health can help patients who are prescribed ...
FEBRUARY 21, 2025

The Key Drivers of Specialty Pharmacy Customer Satisfaction
Communication with the pharmacy team, trust and confidence in a pharmacist or nurse, and the ability to obtain ...
APRIL 19, 2024

Despite Some Setbacks, Strong Specialty Pipeline Seen in 2024
2023 was a record year for new drug approvals, and while 2024 will probably not exceed that record, specialty ...
FEBRUARY 15, 2024

Innovation, COVID-19 Vaccines Will Drive Global Rx Spending
Medicine spending through the next five years will be driven by global COVID-19 vaccinations and new innovations in ...
APRIL 7, 2023

Orphan Drugs Take Specialty Rx Spotlight in 2022
With 40 specialty medications approved by the FDA in 2021, accounting for 75% of all medications approved by the ...
DECEMBER 16, 2022

Rich Pipeline for Specialty Drugs
SPC Editorial Director David Bronstein talks with Aimee Tharaldson, PharmD, senior clinical consultant, ...
OCTOBER 30, 2017

First PCSK9 Outcomes Data Pushed to 2017
Providers, payors and patients will have to wait a little longer for highly anticipated outcomes data on the new ...
JUNE 23, 2016

Specialty Drugs Added $87 to Each Insured’s Tab in 2014
The high cost of specialty drugs affects everyone, adding $87 to each insured person's bill in 2014.
JUNE 2, 2016

Rare Diseases and Oncology Top List of 2015 Specialty Drug Approvals
Rare diseases and oncology topped the list of new drug approvals in 2015, according to a new Diplomat report.
JANUARY 19, 2016
